Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
20.36
+0.66 (3.35%)
At close: Nov 25, 2025, 4:00 PM EST
20.37
+0.01 (0.05%)
After-hours: Nov 25, 2025, 4:00 PM EST
Sanara MedTech Revenue
Sanara MedTech had revenue of $26.33M in the quarter ending September 30, 2025, with 21.51% growth. This brings the company's revenue in the last twelve months to $101.88M, up 30.52% year-over-year. In the year 2024, Sanara MedTech had annual revenue of $86.67M with 33.36% growth.
Revenue (ttm)
$101.88M
Revenue Growth
+30.52%
P/S Ratio
1.66
Revenue / Employee
$722,536
Employees
141
Market Cap
181.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 86.67M | 21.68M | 33.36% |
| Dec 31, 2023 | 64.99M | 19.15M | 41.77% |
| Dec 31, 2022 | 45.84M | 21.70M | 89.87% |
| Dec 31, 2021 | 24.14M | 8.56M | 54.90% |
| Dec 31, 2020 | 15.59M | 3.82M | 32.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SMTI News
- 6 days ago - Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd - GlobeNewsWire
- 13 days ago - Sanara MedTech Inc. (SMTI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Sanara MedTech Inc. Reports Third Quarter 2025 Financial Results (Unaudited) - GlobeNewsWire
- 14 days ago - Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business - GlobeNewsWire
- 7 weeks ago - Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025 - GlobeNewsWire
- 2 months ago - Sanara MedTech: Growth Remains Strong As Debt Concerns Recede - Seeking Alpha
- 3 months ago - Sanara MedTech Inc. Announces Chief Executive Officer Transition - GlobeNewsWire
- 3 months ago - Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025 - GlobeNewsWire